Full Committee Hearing - Prescription Drug Shortages: Examining a Public Health Concern and Potential Solutions
Committee:
106 Dirksen Senate Office Building
Date:
Thursday, December 15 2011, 10:00 AM
Witnessesreturn to top
Panel I
-
Hon. Amy Klobuchar , United States Senator, Minnesota
Panel II
-
Sherry Glied, Ph.D , Assistant Secretary for Planning and Evaluation, Department of Health and Human Services, Washington, DC
-
Sandra Kweder, M.D , Deputy Director, Office of New Drugs, FDA, Washington, DC
Panel III
-
Marcia G. Crosse, Ph.D , Director, Health Care, Government Accountability Office, Washington, DC
-
Murray Aitken , Senior Vice President, Healthcare Insight, IMS, Parsippany, NJ
-
Ralph G. Neas, J.D. , Chief Executive Officer, Generic Pharmaceutical Association, Washington, DC
-
John M. Maris, M.D , Chief, Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA
Recent News
- Alexander Opposes Nominees to NLRB Who Remained on Board After Court Found Their Appointments Unconstitutional [Ranking Member]
- Senate Health Committee Passes Alexander and Colleagues’ Bill to Fix Responsibility for Safety of Sterile Compounded Drugs [Ranking Member]
- Harkin Statement on HELP Committee Approval of a Full Slate of Five Nominees to the NLRB [Chairman]
- Harkin Statement on HELP Committee Passage of the Pharmaceutical Compounding Quality and Accountability Act and the Drug Supply Chain Security Act [Chairman]
- Harkin, Alexander, Roberts, Franken Release Report Outlining Urgent Need for Clear Regulatory Guidelines of Drug Compounders as Committee Approves Legislation [Ranking Member]
.JPG)
